Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a monoclonal antibody therapy in patients with lymphoma or colon cancer unresponsive to vaccine therapy; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Lymphoma

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Lymphoma | Phase 1 | Status: COMPLETED